Clinical Genitourinary Cancer

SJR Rank #4,516H-index: 62SJR: 1.050Best quartile: Q1APC: US$3,530
Journal website: aims, scope and author guidelines
Publisher

Elsevier Inc.

Country

United States

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • UrologyQ1
  • OncologyQ2

Areas: Medicine

Most published research topics

Bladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentUrinary and Genital Oncology StudiesCancer Immunotherapy and BiomarkersMultiple and Secondary Primary CancersRenal and related cancersFerroptosis and cancer prognosisCancer, Lipids, and Metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025055110165220

Detailed Information

ISSN

1558-7673, 1938-0682

SJR Best Quartile

Q1

Region

Northern America

Citations per Document (2 years)

2.51

References per Document

29.51

Coverage

2005-2026

Scope

Clinical Genitourinary Cancer is a peer-reviewed journal that publishes original articles describing various aspects of clinical and translational research in genitourinary cancers. Clinical Genitourinary Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of genitourinary cancers. The main emphasis is on recent scientific developments in all areas related to genitourinary malignancies. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Metrics from SCImago Journal Rank 2025. View on SCImago